[English] 日本語
![](img/lk-miru.gif)
- PDB-4gl9: Crystal structure of inhibitory protein SOCS3 in complex with JAK... -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 4gl9 | ||||||
---|---|---|---|---|---|---|---|
Title | Crystal structure of inhibitory protein SOCS3 in complex with JAK2 kinase domain and fragment of GP130 intracellular domain | ||||||
![]() |
| ||||||
![]() | transferase/transferase inhibitor / kinase inhibitor receptor cytokine signalling / phosphorylation / transferase-transferase inhibitor complex | ||||||
Function / homology | ![]() response to granulocyte macrophage colony-stimulating factor / IFNG signaling activates MAPKs / positive regulation of cell activation / Regulation of IFNG signaling / : / PTK6 Activates STAT3 / Signaling by Erythropoietin / Growth hormone receptor signaling / Interleukin-4 and Interleukin-13 signaling / oncostatin-M receptor activity ...response to granulocyte macrophage colony-stimulating factor / IFNG signaling activates MAPKs / positive regulation of cell activation / Regulation of IFNG signaling / : / PTK6 Activates STAT3 / Signaling by Erythropoietin / Growth hormone receptor signaling / Interleukin-4 and Interleukin-13 signaling / oncostatin-M receptor activity / Prolactin receptor signaling / IL-6-type cytokine receptor ligand interactions / Interleukin-20 family signaling / leukemia inhibitory factor receptor activity / MAPK3 (ERK1) activation / MAPK1 (ERK2) activation / Interferon gamma signaling / Interleukin-12 signaling / Interleukin-27 signaling / Signaling by CSF3 (G-CSF) / Erythropoietin activates RAS / triglyceride mobilization / Interleukin-23 signaling / interleukin-6 receptor activity / interleukin-6 binding / Interleukin-6 signaling / Interleukin-35 Signalling / oncostatin-M receptor complex / Interferon alpha/beta signaling / Inactivation of CSF3 (G-CSF) signaling / ciliary neurotrophic factor receptor binding / Signaling by SCF-KIT / RAF activation / ciliary neurotrophic factor receptor complex / interleukin-27-mediated signaling pathway / interleukin-6 receptor complex / Cyclin D associated events in G1 / negative regulation of tyrosine phosphorylation of STAT protein / Erythropoietin activates Phosphoinositide-3-kinase (PI3K) / : / RAF/MAP kinase cascade / Interleukin receptor SHC signaling / regulation of Notch signaling pathway / interleukin-6 receptor binding / interleukin-11-mediated signaling pathway / cellular response to interleukin-17 / negative regulation of heart contraction / branching involved in labyrinthine layer morphogenesis / Factors involved in megakaryocyte development and platelet production / placenta blood vessel development / nuclear receptor-mediated mineralocorticoid signaling pathway / histone H3Y41 kinase activity / activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway / positive regulation of growth factor dependent skeletal muscle satellite cell proliferation / Interleukin-3, Interleukin-5 and GM-CSF signaling / symbiont-induced defense-related programmed cell death / mammary gland epithelium development / regulation of postsynapse to nucleus signaling pathway / positive regulation of growth hormone receptor signaling pathway / Neddylation / positive regulation of astrocyte differentiation / Antigen processing: Ubiquitination & Proteasome degradation / granulocyte macrophage colony-stimulating factor receptor complex / granulocyte-macrophage colony-stimulating factor signaling pathway / intestinal epithelial cell development / collagen-activated signaling pathway / interleukin-12 receptor binding / interleukin-5-mediated signaling pathway / response to interleukin-12 / 1-phosphatidylinositol-3-kinase regulator activity / myeloid cell differentiation / protein tyrosine kinase inhibitor activity / post-embryonic hemopoiesis / interleukin-12 receptor complex / activation of Janus kinase activity / tyrosine phosphorylation of STAT protein / interleukin-23 receptor complex / postsynapse to nucleus signaling pathway / positive regulation of MHC class II biosynthetic process / positive regulation of platelet aggregation / type 1 angiotensin receptor binding / positive regulation of T-helper 17 type immune response / positive regulation of platelet activation / acetylcholine receptor binding / positive regulation of NK T cell proliferation / interleukin-12-mediated signaling pathway / cellular response to interleukin-3 / interleukin-3-mediated signaling pathway / regulation of nitric oxide biosynthetic process / positive regulation of signaling receptor activity / phosphatidylinositol 3-kinase complex / positive regulation of epithelial cell apoptotic process / cytokine receptor activity / positive regulation of natural killer cell proliferation / positive regulation of cell-substrate adhesion / growth hormone receptor binding / response to hydroperoxide / miRNA binding / axon regeneration / growth hormone receptor signaling pathway Similarity search - Function | ||||||
Biological species | ![]() ![]() | ||||||
Method | ![]() ![]() ![]() | ||||||
![]() | Kershaw, N.J. / Murphy, J.M. / Laktyushin, A. / Nicola, N.A. / Babon, J.J. | ||||||
![]() | ![]() Title: SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. Authors: Kershaw, N.J. / Murphy, J.M. / Liau, N.P. / Varghese, L.N. / Laktyushin, A. / Whitlock, E.L. / Lucet, I.S. / Nicola, N.A. / Babon, J.J. | ||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 341.6 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 289.8 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Arichive directory | ![]() ![]() | HTTPS FTP |
---|
-Related structure data
Similar structure data |
---|
-
Links
-
Assembly
Deposited unit | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
2 | ![]()
| ||||||||
3 | ![]()
| ||||||||
4 | ![]()
| ||||||||
Unit cell |
|
-
Components
#1: Protein | Mass: 35111.883 Da / Num. of mol.: 4 / Fragment: Kinase domain (unp residues 836-1132) Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() ![]() References: UniProt: G5E852, UniProt: Q62120*PLUS, non-specific protein-tyrosine kinase #2: Protein/peptide | Mass: 1605.573 Da / Num. of mol.: 4 / Fragment: unp residues 750-764 / Source method: obtained synthetically / Source: (synth.) ![]() ![]() #3: Protein | Mass: 15641.506 Da / Num. of mol.: 4 Fragment: chimeric fusion of Intracellular domain (unp residues 22-128 and 163-185) Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() ![]() #4: Chemical | ChemComp-IZA / #5: Chemical | ChemComp-PO4 / | |
---|
-Experimental details
-Experiment
Experiment | Method: ![]() |
---|
-
Sample preparation
Crystal | Density Matthews: 4.23 Å3/Da / Density % sol: 70.95 % |
---|---|
Crystal grow | Temperature: 298 K / Method: vapor diffusion, hanging drop / pH: 4.2 Details: 0.33M di-potassium hydrogen phosphate, 1.67M sodium dihydrogen phosphate, 0.1M phosphate-citrate, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K |
-Data collection
Diffraction | Mean temperature: 100 K |
---|---|
Diffraction source | Source: ![]() ![]() ![]() |
Detector | Type: ADSC QUANTUM 315r / Detector: CCD / Date: Apr 2, 2011 |
Radiation | Monochromator: Si 111 CHANNEL / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 0.95371 Å / Relative weight: 1 |
Reflection | Resolution: 3.9→45.584 Å / Num. obs: 31617 / % possible obs: 99.9 % / Observed criterion σ(F): 0 / Observed criterion σ(I): -3 |
-
Processing
Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: ![]()
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: LAST / Resolution: 3.9→45.58 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS refinement shell |
|